Brachytherapy for the prevention of restenosis in peripheral arteries following percutaneous transluminal angioplasty (PTA) of the femoropopliteal system.
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D001157:Arterial Occlusive Diseases / Q000628:therapy; D054598:Blue Cross Blue Shield Insurance Plans; D001918:Brachytherapy; D023903:Coronary Restenosis / Q000532:radiotherapy* / Q000601:surgery; D017277:Drug Approval; D019317:Evidence-Based Medicine; D005263:Femoral Artery / Q000528:radiation effects; D006801:Humans; D019458:Insurance Coverage; D017063:Outcome Assessment, Health Care; D011150:Popliteal Artery / Q000528:radiation effects; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration